In the international SUMMIT trial, adults with heart failure preserved ejection fraction (HFpEF) and obesity taking tirzepatide for up to 3 years had a reduced combined risk of worsening heart failure ...

Eli Lilly's tirzepatide cut the risk of developing type 2 diabetes for people with pre-diabetes by 94%, according to new ...

Commissions do not affect our editors' opinions or evaluations. Gantt charts are excellent project management tools. They use horizontal bars to denote the amount of work done in certain periods ...

BIGBANG’s G-Dragon is back—and topping music charts across the globe! On October 31 at 6 p.m. KST, G-Dragon made his long-awaited solo return with his new pre-release single “POWER.” ...

Preceded by the singles Alone and A Fragile Thing, and launched alongside focus track All I Ever Am, the band will be hoping to secure a second UK chart-topper with the record. The Cure ...

Less than a month after the FDA removed Eli Lilly’s tirzepatide from its shortage ... its shortage list to note that the 0.25 mg starter dose of Novo’s semaglutide-based obesity med Wegovy ...

It also lifted guidance by $2 billion after the first quarter, citing booming demand for its tirzepatide products. In making the latest adjustment, Lilly cited its "prudent" rollout as it works to ...

including versions that are manipulated as to dose and form solely to try to evade legal restrictions.” The American Society of Health-System Pharmacists (ASHP) reports that tirzepatide is not ...

Proper dosing can also be challenging with compounded forms of the drugs. Companies that work the system For people who cannot afford a compounding pharmacy product, or cannot get a valid prescription ...

Taylor Hill/WireImage Bunnie Xo is sharing an update on how she’s feeling on tirzepatide, joking she’s “never gonna be a sex symbol” because she only makes headlines for “how I wear diap ...

Immunocompromised people and those who are age 65 or older should get a second dose of the 2024-2025 COVID-19 vaccine, according to the latest recommendations from the Centers for Disease Control ...

Earlier this month, the FDA declared an end to the shortage of Lilly’s tirzepatide, sold as Mounjaro for diabetes and Zepbound for obesity, after almost two years. By law, that should have ...